Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study

[1]  T. Yoshino,et al.  A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease , 2017, Modern rheumatology.

[2]  H. Sekiguchi,et al.  IgG4‐Related Disease: Retrospective Analysis of One Hundred Sixty‐Six Patients , 2016, Arthritis & rheumatology.

[3]  H. Sugimoto,et al.  Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis , 2016, Gut.

[4]  P. Lipsky,et al.  Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. , 2015, Rheumatology.

[5]  A. Fernández-Codina,et al.  IgG4-Related Disease: Results From a Multicenter Spanish Registry , 2015, Medicine.

[6]  I. Narita,et al.  Recovery of renal function after glucocorticoid therapy for IgG4-related kidney disease with renal dysfunction , 2015, Clinical and Experimental Nephrology.

[7]  O. Matsui,et al.  IgG4-Related Disease: Dataset of 235 Consecutive Patients , 2015, Medicine.

[8]  K. Imai,et al.  Everyday clinical practice in IgG4-related dacryoadenitis and/or sialadenitis: Results from the SMART database , 2015, Modern rheumatology.

[9]  M. Nojima,et al.  Identification of relapse predictors in IgG4-related disease using multivariate analysis of clinical data at the first visit and initial treatment. , 2015, Rheumatology.

[10]  K. Okazaki,et al.  Comprehensive Diagnostic Criteria for IgG4-Related Disease , 2014 .

[11]  T. Shimosegawa,et al.  Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis , 2014, Journal of Gastroenterology.

[12]  Masao Tanaka,et al.  IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. , 2014, Journal of clinical and experimental hematopathology : JCEH.

[13]  T. Hibi,et al.  Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 , 2012, Modern rheumatology.

[14]  E. Andrès,et al.  IgG4-Related Systemic Disease: Features and Treatment Response in a French Cohort: Results of a Multicenter Registry , 2012, Medicine.

[15]  Hisanori UmeharaKazuichi.  A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2012 .

[16]  K. Uchida,et al.  Recent Concepts of Autoimmune Pancreatitis and IgG4-Related Disease , 2011, Clinical reviews in allergy & immunology.

[17]  J. Stone,et al.  Treatment approaches to IgG4-related systemic disease , 2011, Current opinion in rheumatology.

[18]  Y. Nakanuma,et al.  IgG4-Related Disease: A Cross-sectional Study of 114 Cases , 2010, The American journal of surgical pathology.

[19]  T. Shimosegawa,et al.  Standard steroid treatment for autoimmune pancreatitis , 2009, Gut.

[20]  B. Petersen,et al.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. , 2008, Gastroenterology.

[21]  T. Mimori.  The present and future perspectives of Modern Rheumatology , 2006 .

[22]  Y. Shinomura,et al.  Beneficial effects of steroid therapy for Mikulicz's disease. , 2005, Rheumatology.

[23]  Hiroyuki Yamamoto,et al.  Elevated IgG4 concentrations in serum of patients with Mikulicz's disease , 2004, Scandinavian journal of rheumatology.

[24]  S. Kawa,et al.  Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis , 2002, The Lancet.

[25]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.